.jpg)
Correction of information on both monthly and accumulated sales revenue from January to November in 2023
2024.2.29
...
.jpg)
TSH Board of Directors resolved to convene the 2024 Annual General Shareholders's Meeting
2024.2.27
...
.jpg)
.jpg)
TSH Board of Directors Approved Financial Statements For the Year Ended December 31, 2023
2024.2.27
...
.jpg)
Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO., LTD., regarding the BOD resolved to convene the 2024 Annual General Shareholders' Meeting
2024.2.22
...
TSH announces TFDA acceptance TSH announces TFDA acceptance Tyrvaya® for Dry Eye Nasal Spray, expected approval by late 2024.
2024.1.3
...
